DMD Noab BioDiscoveries - Shaping Drug Discovery

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Drug Metabolism and Disposition Fast Forward
First published on November 22, 2005; DOI: 10.1124/dmd.105.007211


0090-9556/06/3402-318-323$20.00
DMD 34:318-323, 2006

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
dmd.105.007211v1
34/2/318    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gupta, A.
Right arrow Articles by Hammarlund-Udenaes, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gupta, A.
Right arrow Articles by Hammarlund-Udenaes, M.

BRAIN DISTRIBUTION OF CETIRIZINE ENANTIOMERS: COMPARISON OF THREE DIFFERENT TISSUE-TO-PLASMA PARTITION COEFFICIENTS: Kp, Kp,u, AND Kp,uu

Anubha Gupta, Pierre Chatelain, Roy Massingham, E. Niclas Jonsson, and Margareta Hammarlund-Udenaes

Division of Pharmacokinetics and Drug Therapy, Department of Pharmaceutical Biosciences, Uppsala University, Uppsala, Sweden (A.G., E.N.J., M.H.U.); and UCB Société Anonyme, Braine-l'Alleud, Belgium (P.C., R.M.)

The objective of this study was to compare the blood-brain barrier (BBB) transport and brain distribution of levo- (R-CZE) and dextrocetirizine (S-CZE). Microdialysis probes, calibrated using retrodialysis by drug, were placed into the frontal cortex and right jugular vein of eight guinea pigs. Racemic CZE (2.7 mg/kg) was administered as a 60-min i.v. infusion. Unbound and total concentrations of the enantiomers were measured in blood and brain with liquid chromatography-tandem mass spectrometry. The brain distribution of the CZE enantiomers were compared using the parameters Kp, Kp,u, Kp,uu, and Vu,br. Kp compares total brain concentration to total plasma concentration, Kp,u compensates for binding in plasma, whereas Kp,uu also compensates for binding within the brain tissue and directly quantifies the transport across the BBB. Vu,br describes binding within the brain. The stereoselective brain distribution indicated by the Kp of 0.22 and 0.04 for S- and R-CZE, respectively, was caused by different binding to plasma proteins. The transport of the CZE enantiomers across the BBB was not stereoselective, since the Kp,uu was 0.17 and 0.14 (N.S.) for S- and R-CZE, respectively. The Kp,uu values show that the enantiomers are effluxed to a large extent across the BBB. The Vu,br of approximately 2.5 ml/g brain was also similar for both the enantiomers, and the value indicates high binding to brain tissue. Thus, when determining stereoselectivity in brain distribution, it is important to study all factors governing this distribution, binding in blood and brain, and the BBB equilibrium.


Address correspondence to: Dr. Margareta Hammarlund-Udenaes, Professor, Division of Pharmacokinetics and Drug Therapy, Department of Pharmaceutical Biosciences, Uppsala University, Box 591, SE-751 24 Uppsala, Sweden. E-mail: mhu{at}farmbio.uu.se




This article has been cited by other articles:


Home page
Drug Metab. Dispos.Home page
M. Friden, A. Gupta, M. Antonsson, U. Bredberg, and M. Hammarlund-Udenaes
In Vitro Methods for Estimating Unbound Drug Concentrations in the Brain Interstitial and Intracellular Fluids
Drug Metab. Dispos., September 1, 2007; 35(9): 1711 - 1719.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
Y. Zhuang, C. H. Fraga, K. E. Hubbard, N. Hagedorn, J. C. Panetta, C. M. Waters, and C. F. Stewart
Topotecan Central Nervous System Penetration Is Altered by a Tyrosine Kinase Inhibitor
Cancer Res., December 1, 2006; 66(23): 11305 - 11313.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
E. Bostrom, U. S. H. Simonsson, and M. Hammarlund-Udenaes
In Vivo Blood-Brain Barrier Transport of Oxycodone in the Rat: Indications for Active Influx and Implications for Pharmacokinetics/Pharmacodynamics
Drug Metab. Dispos., September 1, 2006; 34(9): 1624 - 1631.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2006 by the American Society for Pharmacology and Experimental Therapeutics.